Awesome, but it's such a shame that US VCs are too busy putting $250B into data centers so we can have AI slop, when just 1/10000th of that, a rounding error, would have allowed a trial like this in the US.
And the funding system assures we can never do this within a university
And the funding system assures we can never do this within a university
In three patients with refractory epilepsy, hippocampal chemogenetic therapy plus low-dose clozapine was associated with a mean seizure-frequency reduction of 92.6%. Adverse events were grade 1 or 2. Full study results: nej.md/4AgtyhzView quoted post on X
